Microneedles For Easy Delivery Of Drugs Into Eye

microneedles

A number of eye conditions can be treated by administering drugs directly into the eye. Yet, conventional needles have a bunch of drawbacks, including the patients’ fear of needles entering such fragile parts of the body and the difficulty of accurately administering medication into a targeted region of the eye. For glaucoma, for example, eye drops are prescribed which have a shorter active lifetime and are often skipped by the patients. An easy injection that works for months at a time would help control the disease considerably better.

Researchers at Georgia Tech and Emory University have been working on microneedles and formulations to safely and effectively deliver drugs into the eye. The microneedles are designed to only penetrate to the correct depth and the formulations need to be viscous enough to stay in place and release their therapeutic compounds in a controlled fashion. The researchers have already tested the microneedles on laboratory animals and showed that they can place drugs within the targeted sections of the eye.

More from Georgia Tech:

The microneedle therapy would inject drugs into space between two layers of the eye near the ciliary body, which produces the aqueous humor. The drug is retained near the injection side because it is formulated for increased viscosity. In studies with an animal model, the researchers were able to reduce intraocular pressure through the injections, showing that their drug got to the proper location in the eye.

Because the injection narrowly targets delivery of the drug, researchers were able to bring about a pressure reduction by using just one percent of the amount of drug required to produce a similar decline with eye drops.

To treat corneal neovascularization, the researchers took a different approach, coating solid microneedles with an antibody-based drug that prevents the growth of blood vessels. They inserted the coated needles near the point of an injury, keeping them in place for approximately one minute until the drug dissolved into the cornea.

In an animal model, placement of the drug halted the growth of unwanted blood vessels for about two weeks after a single application.

Source: www.medgadget.com

Recent Posts

Frontier Nursing University Introduces Office of Student Engagement, Access, and Success
Frontier remains committed to fostering an environment that values and supports all students and honors diverse backgrounds, perspectives, and experiences. VERSAILLES, Ky. – Frontier Nursing...
Read More
The Role of Language and Culture in Patient Care
In today’s increasingly diverse healthcare landscape, language and culture are far more than communication tools, they’re fundamental components of high-quality, patient-centered care. When language...
Read More
Honoring Hispanic Nurses Who Shaped Health Care
Every year during Hispanic Heritage Month, we highlight the powerful contributions of Hispanic and Latinx Nurses, those who broke barriers, built institutions, and continue to lead change in health...
Read More

Subscribe to Email Our Newsletter

Education_Award_Square